48,466
edits
Difference between revisions of "Reactive changes"
Jump to navigation
Jump to search
→See also
| (7 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
# Inflammation. | # Inflammation. | ||
# Nuclear changes compatible with inflammation. | # Nuclear changes compatible with inflammation. | ||
# The absence of both neoplasia and the | # The absence of both neoplasia ''and'' the suspicion of neoplasia, i.e. it implies benignancy. | ||
'''Reactive inflammatory changes''' and ''inflammatory changes''' can be considered synonyms. | '''Reactive inflammatory changes''' and '''inflammatory changes''' can be considered synonyms. | ||
==General== | ==General== | ||
| Line 26: | Line 26: | ||
*Inflammation - any type (e.g. [[neutrophil|neutrophilic]], [[plasma cells|plasmacytic]], lymphoplasmacytic). | *Inflammation - any type (e.g. [[neutrophil|neutrophilic]], [[plasma cells|plasmacytic]], lymphoplasmacytic). | ||
*+/-Proliferation (e.g. mitotic figures) or changes suggestive of proliferation (e.g. hyperplasia). | *+/-Proliferation (e.g. mitotic figures) or changes suggestive of proliferation (e.g. hyperplasia). | ||
Notes: | |||
*Cytoplasmic changes may be present. | |||
DDx: | DDx: | ||
*[[Waffle diagnosis]] | *Normal. | ||
**Terminology dependent on the anatomical site. | *[[Waffle diagnosis]] - nuclear changes of unknown significance. | ||
**Terminology dependent on the anatomical site, e.g. [[indefinite for dysplasia]], [[ASCUS]], [[ASAP]]. | |||
*[[Nuclear atypia]]. | *[[Nuclear atypia]]. | ||
**This is often qualified as it may represent neoplastic process or a benign process | **This is often qualified as it may represent a neoplastic process or a benign process. | ||
**Common qualifiers: | **Common qualifiers: | ||
***Worrisome lesions: "cannot exclude dysplasia", "suspicious for malignancy". | ***Worrisome lesions: "... cannot exclude dysplasia", "... cannot exclude malignancy", "... suspicious for malignancy". | ||
***Suspected to be benign: "favour benign". | ***Suspected to be benign: "... favour benign". | ||
*[[Malignancy]]. | *[[Malignancy]]. | ||
| Line 42: | Line 46: | ||
*[[NC ratio]]. | *[[NC ratio]]. | ||
*[[Reactive squamous epithelium of the uterine cervix]]. | *[[Reactive squamous epithelium of the uterine cervix]]. | ||
*[[Reactive astrocytes]]. | |||
[[Category:Stuff]] | [[Category:Stuff]] | ||